Clinical trials in Gurnee, IL

17 recruiting studies have a site in or near Gurnee, IL, Illinois.

Top conditions here

All conditions

Showing 17 of 17 studies

RecruitingPhase 3NCT06819878

A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

Sponsor: Hoffmann-La Roche

Chicago, IL · Glenview, IL · Gurnee, IL · +92 more sites

RecruitingPhase 3NCT07185009

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Sponsor: Sanofi

Gurnee, IL · +36 more sites

RecruitingPhase 2NCT07697456

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Sponsor: AbbVie

Des Plaines, IL · Glenview, IL · Gurnee, IL · +57 more sites

RecruitingPhase 3NCT07816367

A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

Sponsor: Kallyope Inc.

Gurnee, IL · Skokie, IL · +70 more sites

RecruitingPhase 3NCT06430801

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Sponsor: Merck Sharp & Dohme LLC

Chicago, IL · Evanston, IL · +84 more sites

RecruitingPhase 3NCT07351045

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Sponsor: Hoffmann-La Roche

Gurnee, IL · Schaumburg, IL · Skokie, IL · +41 more sites

RecruitingPhase 2NCT07186101

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

Sponsor: Eli Lilly and Company

Belleville, IL · Chicago, IL · Des Plaines, IL · +37 more sites

RecruitingPhase 3NCT07564414

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

Sponsor: Novo Nordisk A/S

Chicago, IL · Gillespie, IL · Gurnee, IL · +96 more sites

RecruitingPhase 2NCT07845487

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

Sponsor: Palisade Bio

Des Plaines, IL · Glenview, IL · Gurnee, IL · +27 more sites

RecruitingPhase 3NCT07761117

A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

Sponsor: AstraZeneca

Champaign, IL · Chicago, IL · Gurnee, IL · +117 more sites

RecruitingPhase 3NCT07184931

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Sponsor: Sanofi

Chicago, IL · Des Plaines, IL · Glenview, IL · +122 more sites

RecruitingPhase 3NCT07184944

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Sponsor: Sanofi

Gurnee, IL · +33 more sites

RecruitingPhase 3NCT06677060

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

Sponsor: AstraZeneca

Champaign, IL · Chicago, IL · +195 more sites

RecruitingPhase 3NCT07797335

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

Sponsor: Novo Nordisk A/S

Gurnee, IL · Hazel Crest, IL · Oak Brook, IL · +106 more sites

RecruitingPhase 2NCT06636656

A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis

Sponsor: Boehringer Ingelheim

Gurnee, IL · +13 more sites

RecruitingPhase 3NCT07184996

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Sponsor: Sanofi

Chicago, IL · Des Plaines, IL · Glenview, IL · +115 more sites

RecruitingPhase 2NCT07113522

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Sponsor: Mirador Therapeutics, Inc.

Glenview, IL · Gurnee, IL · +44 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.